Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06320522
Other study ID # R82053/RE002
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 15, 2023
Est. completion date May 2024

Study information

Verified date March 2024
Source University of Oxford
Contact Leanne Hodson, PhD
Phone 01865 857224
Email leanne.hodson@ocdem.ox.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The kinetics of circulating βHB following ingestion of the ketone monoester are dependent on several variables that determine the balance between appearance into, and disappearance from, the bloodstream. These dynamics have been well characterised in fasted humans but in the real world the ketone monoester is likely to be ingested in a fed state, pertinently within athletic spheres consumption would proceed a substantial high-carbohydrate meal. Within this, it is unclear how metabolism under exogenous ketosis might be affected in a fed versus fasted state. This four-arm crossover study looks to characterise the relationship between feeding status, βHB pharmacokinetics, and resting metabolism. As exogenous ketosis is known to reduce circulating glucose levels, this study will also explored if hepatic metabolism - for example, de novo lipogenesis - might consequently be altered, with implications for metabolic disease states such as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and type II diabetes. Participants will be asked to consume either the ketone monoester drink or a placebo drink when fasted and when having previously consumed a meal.


Description:

Adults free from metabolic disease will be recruited for this randomised-counterbalanced crossover study. Participants will attend four study visits. Participants will consume a prescribed isocaloric high-carbohydrate diet for two days prior to each visit to standardise dietary intake. For two of these visits participants will remain 'fasted' throughout, and for the two 'fed' visits they will consume a mixed-nutrient breakfast meal. The breakfast for the 'fed' visits will provide 2g∙kg-1 bodyweight of carbohydrate. Heavy water (D2O) will be consumed the evening preceding, and during, each fed study visit to achieve ~0.4% plasma enrichment, in order to quantify the contribution of hepatic de novo lipogenesis to VLDL-TG. At these visits they will consume either a ketone monoester (KME) or taste/volume-matched placebo (PLA) drink. The nature of this drink will be single blinded and consumed after the breakfast meal during the 'fed' visits. Therefore the four visits will be as follows: fed-KME, fed-PLA, fasted-KME, fasted-PLA. Blood and breath samples will be collected at fasting and across a 6 hour period after consuming the KME or PLA drink. Subjective measures of gastrointestinal distress and appetite will also be assessed. This study aims to establish how feeding state might affect the appearance of βHB into the bloodstream, circulating metabolism, and hepatic metabolism.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date May 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Habitually consuming a mixed macronutrient diet - Fluent in English, no communication impairments, willing & able to give informed consent for participation in the study - Not currently taking any medication (except the contraceptive pill) - No food allergies incompatible with the supplement drinks or with the standardised breakfast where a suitable substitution cannot be practically made - Female-only - on contraception (pill/implant/coil/etc); not pregnant/currently breastfeeding; pre-menopausal; not undertaking hormone replacement therapy (HRT) - In the investigator's opinion - able and willing to comply with all study requirements Exclusion Criteria: - Significant cardiovascular disease or metabolic risk factors, or family history of it, on health screening questionnaire - Food allergies incompatible with the supplement drinks or standardised breakfast - Having been on a ketogenic diet in the 6 months prior to enrolment - Any other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study/the participant's ability to participate in the study - Concurrently a participant in any other dietary intervention study/have taken part in one within 1 month of enrolment - Diabetic - Pregnant or breastfeeding - Known history of moderate-to-severe motion sickness

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Ketone Monoester
Commercial dietary supplement intended raise blood ketone body levels
Placebo
Placebo drink (2mM sucrose octaacetate) taste and volume matched to the ketone monoester drinks

Locations

Country Name City State
United Kingdom Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM) Oxford Oxfordshire

Sponsors (1)

Lead Sponsor Collaborator
University of Oxford

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Plasma ß-hydroxybutyrate (ßHB) kinetics Changes in concentration of plasma ßHB (mM) over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Primary Plasma glucose kinetics Changes in concentration of plasma glucose (mM) over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Primary Postprandial de novo lipogenesis (DNL) DNL in the fed visits - quantified as the incorporation of deuterium from heavy water into newly synthesised palmitate within very low-density lipoprotein-triglyceride (VLDL-TG) 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Plasma biochemistry Changes in concentration of plasma lactate, insulin, nonesterified fatty acid (NEFA), triglyceride (TG), glycerol, and urea (all mM) over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Very low-density lipoprotein-triglyceride (VLDL-TG) fatty acid composition Changes in fatty acid composition (mol%) of VLDL-TG over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Breath acetone Changes in concentration of breath acetone (arbitrary units) over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Urine volume Volume (ml) of urine over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Urine composition ßHB concentration (mM) of urine over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Indirect calorimetry Changes in Respiratory Quotient (RQ; unitless) over the post-drink time period 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Subjective measures of appetite Changes in perceptions of appetite over the post-drink period Appetite sensations will be assessed using a validated 10-point visual analogue scale (score: 0 - minimal, 10 - maximal) which will be presented to participants on printed paper This posed four questions - "How hungry do you feel?", "How full do you feel?", "How satisfied do you feel?", and "How much do you think you can eat now?" 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
Secondary Subjective measures of gastrointestinal distress Changes in perceptions of gastrointestinal (GI) distress over the post-drink period GI distress will be assessed using a literature-standard 0-8 Likert scale questionnaire quantified at upper abdominal (reflux, bloating, nausea, vomiting), lower abdominal (cramps, flatulence, abdominal pain, diarrhoea), and systemic (dizziness, headache, muscle cramp, urge to urinate) levels (severity score: 0 - minimal, 8 - maximal) 7 hours (fasted arrival through to 6 hours after consumption of the KME or PLA drink)
See also
  Status Clinical Trial Phase
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04817176 - MI-CBT Adherence Program for Lifestyle Interventions in Older Adults Early Phase 1
Completed NCT04565444 - Ketones and Muscle Protein Synthesis N/A
Not yet recruiting NCT06418074 - Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity N/A
Not yet recruiting NCT03954665 - Ketone Supplementation and Exercise Performance N/A
Active, not recruiting NCT06097754 - Intermittent Exogenous Ketosis (IEK) at High Altitude N/A
Terminated NCT03790436 - Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet N/A
Completed NCT03299543 - Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate
Recruiting NCT04004676 - Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise N/A
Not yet recruiting NCT03659825 - Ketone Esters for Optimization of Cognitive Performance in Hypoxia N/A
Active, not recruiting NCT04156477 - Markers of Appetite Regulation During Exogenous Ketosis N/A
Completed NCT04130724 - Characterization of a Portable Solid-State Breath Acetone Testing Device for Real-Time Ketosis Status
Recruiting NCT04594265 - Weight-Adjusted Dosing of 3-OHB in Patients With Chronic Heart Failure Phase 2
Not yet recruiting NCT04576026 - Exogenous Ketone Supplementation and Cognitive Function During Exercise N/A
Completed NCT05558488 - The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response N/A
Recruiting NCT03564002 - Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
Completed NCT04309214 - Market Research - Acceptability Study for New MCT Fat Products N/A
Completed NCT05588427 - Effect of Ketone Ester Supplementation on Hypoxic Tolerance N/A
Recruiting NCT05656339 - Metabolic Effects of Whey Protein Supplementation After Fasting in Volunteers N/A